who should not use a glp 1 GLP-1 nausea: How to handle GLP-1s' most common side effect Why I'm Choosing Not to
Description
the reduced lateral diffusion of GLP-1R V229A could therefore be due to the mutant receptor existing as a subpopulation of pre-clustered, higher order oligomeric assemblies in absence of agonist stimulation, predicted to cause a decrease in the movement of these clusters and potentially hinder cholesterol binding

Patients experience improved metabolic health, including better blood sugar levels, cholesterol, and blood pressure

Reduce insulin doses by 20 to 30 percent when initiating GLP-1 treatment

Lower cases were reported in the thyroid, bladder, colorectal, and pancreas compared to a treatment period of 104 weeks with 0.5 mg of semaglutide, which yielded 155 cases of neoplasm

a similar idea applies in QC for manufacturing
